MetaCap

Outset Medical (OM) vs Precision Optics (POCI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Precision Optics (POCI) has outperformed Outset Medical (OM) over the past year, losing 10.4% versus a loss of 34.5%. Over five years, POCI leads with a -37.9% price change compared with -99.6% for OM. Outset Medical is the larger company by market cap ($53.0 million vs $45.3 million), about 1.2 times the size, while Precision Optics is growing revenue faster (+65.2% vs +5.1%).

Precision Optics converts more of its revenue into profit, with a net margin of -11.5% versus -68.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OM-34.50%POCI-10.43%
+36%-1%-38%
Nov 21, 20251 yearNov 20, 2026
OM-99.62%POCI-39.23%
+16%-45%-105%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OM versus POCI key metrics
MetricOMPOCI
Share price$2.81$4.12
Market cap$53.03M$45.30M
1-day change-3.44%+1.41%
YTD return-24.26%-1.67%
1-year return-34.50%-10.43%
5-year return-99.61%-37.86%
Forward P/E—206.00
EPS (TTM)$-3.78$-0.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$119.48M$31.53M
Revenue growth (YoY)+5.09%+65.16%
Net income (latest FY)$-81.65M$-3.63M
Gross margin39.13%17.22%
Operating margin-55.83%-11.13%
Net margin-68.34%-11.51%
52-week high$6.49$6.15
52-week low$2.77$3.55
Distance from 52-week high-56.70%-33.01%
Analyst consensusbuystrong_buy
Avg. price target upside+172.95%+94.17%
Average volume140.40K43.00K
Shares outstanding18.87M10.99M
Employees310108
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • POCI has outperformed OM by 24.1 percentage points over the past year.
  • Precision Optics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -68.3 cents for Outset Medical.
  • Precision Optics grew revenue faster in its latest fiscal year (+65.16% vs +5.09%).

About Outset Medical

OM stock →

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees

About Precision Optics

POCI stock →

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees

OM vs POCI FAQ

Which is bigger, Outset Medical or Precision Optics?

Outset Medical (OM) is larger, with a market capitalization of $53.03M compared with $45.30M for Precision Optics (POCI).

Which stock has performed better over the past year, OM or POCI?

POCI returned -10.43% over the past 12 months, compared with -34.50% for OM (price return, excluding dividends). Past performance does not predict future results.

Are Outset Medical and Precision Optics in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons